Latest ArticlesThe U.S. Food and Drug Administration(FDA) approved 37 new drugs into the market in 2022, including 22 chemical small molecules and 15 biological products. According to the prescription information for professionals and the related literature as well as patent information, this review describes the descriptions, indications, mechanism of action, dosage form and strength, adverse reactions, and one synthetic route of the chemical small molecules, and brief information about biological products.
Phage display technology(PDT) is an efficient screening technology in vitro for specific peptides of disease targets. This technology not only can screen out disease-related biomarkers but also serve as a powerful tool for drug research and development. Nowadays, PDT applies widely in the diagnosis and treatment of diseases and drug research. This paper reviews the principle of PDT, and its application in disease diagnosis, treatment, and drug research and development. The existing shortcomings of PDT and its application prospects are discussed to provide references for further research of PDT in modern medicine.
As a sample pretreatment method, solid phase microextraction(SPME) technology is used to enrich trace analytes in samples. It has the characteristics of simple operation, high throughput, low consumption of organic solvents, and automation. The extraction, concentration and injection are integrated into one procedure by this technology, which greatly improves the extraction efficiency. Based on the introduction of SPME technology, this paper reviews the application of SPME in the field of pharmaceutical analysis in recent years, and briefly discusses its limitations and development prospects, which provides a reference for the detection of trace components in complex substrates.
Extracellular vesicles(EVs) are naturally secreted by almost all types of cells, including human cancer cells, under physiological and pathological conditions. In recent years, due to their inherent biocompatibility, high stability, low immunogenicity, and essential role in intercellular communication in the pathological process, they have attracted wide attention and are considered as promising drug delivery vectors. In addition, they could have potential of treating cancer and other diseases. Accurate detection of EVs in vivo is the first critical step in developing EVs therapy. Different markers and imaging methods have been developed to enable non-invasive tracers in vivo, such as optical imaging and radioisotope imaging, which can be used to investigate the biological distribution, migration, and targeting characteristics in vivo of EVs. In this paper, the biological functions of EVs are briefly introduced, and the different imaging techniques available for in vivo tracers are discussed to promote the study of the biological process of EVs in vivo and the application of EVs-based nanomedicines.
Drug nanoparticles are often used to improve the bioavailability of oral drug delivery. However, due to physiological barriers such as mucus layer, P-glycoprotein(P-gp) efflux, and tight junctions in the gastrointestinal tract, the improvement of bioavailability of oral drugs by nanoparticles is limited. Nanoparticles modified with functional materials have become a research hotspot for oral drug delivery strategies due to their functionality, modifiability, and diversity. This study briefly describes the factors that limit the bioavailability of drugs and focuses on the summary of functional nanomaterials that enhance drug bioavailability by improving drug physicochemical properties and overcoming biological barriers to provide references and literature support for the study of drug loading strategies for poorly soluble drugs.
At present, the clinical applications of over 70% of drug candidates are limited due to their poor solubility. Adding hydrotropes is one of the common methods to improve the solubility of poorly soluble drugs. Hydrotropes are nonflammable, easily accessible, eco-friendly, and rapidly recyclable, so the applications of hydrotropes in improving the solubility of poorly soluble drugs are more and more extensive. However, the solubilization mechanisms of many hydrotropes are still unclear, and exploration of solubilization mechanisms is one of the current research hotspots. This paper introduces the classifications of hydrotropes, and focuses on the mechanisms of hydrotropes, including the molecular self-assembly of hydrotropes, the complexation of hydrotropes with solute molecules, and water structure changes, in order to provide theoretical references for applying hydrotropes to improve the solubility of poorly soluble drugs.
The industrial synthetic process of (S)-3-hydroxytetrahydrofuran was improved. (S)-4-Chloro-1,3-butanediol(3) was obtained by reduction of the starting material, ethyl (S)-4-chloro-3-hydroxybutyrate(2), with sodium borohydride in ethanol. The reaction mixture was quenched, followed by evaporation of the solvent. Then, the system was directly heated to give the title compound by ring-closure in water. The continuous extraction was used in the work-up so that the extraction efficiency was improved. After the distillation in vacuum and purification, 1 was obtained in a yield of 76.2% with 99.8% of chemical purity and the ee value greater than 99.8%. The improved synthetic process was low-cost and safe, which was suitable for industrial production.
Hyaluronidase is capable of degrading hyaluronic acid(HA) and has essential applications in biological medicine and drug delivery. The hyaluronate lyase(HylP) from Streptococcus bacteriophage was heterologously expressed and characterized in order to explore hyaluronidase with high activity, high substrate specificity and high stability. The results showed that HylP consisted of 337 amino acids belonged to the polysaccharide lyase family 16(PL16). The recombinant HylP could be expressed as a soluble form in Escherichia coli(DE3) with purified yield of 30 mg/L. The optimal temperature of recombinant HylP was 40 ℃, and the optimal pH value was 6.0. The HylP was stable under the temperature of 35 ℃ and pH 6.0 - 7.0, and it could degrade HA specifically with an activity of 24 u/mg. Enzymatic kinetic analysis showed that Michealis constant(Km) and catalytic constant(kcat) of HylP towards HA were 0.13 mg/mL and 13.80 s–1, respectively. In conclusion, HylP was a mesophilic, highly specific and active lyase towards HA, which had a potential application in producing functional low molecular weight HA.
The biological metal-organic framework(MOF) Ti-MOF-79 with adenine as an organic ligand and Ti as a metal core was synthesized under hydrothermal conditions. Quercetin(1) was used as a drug model to investigate the drug loading and release performance of Ti-MOF-79. The material and the drug-loaded complexes were characterized through transmission electron microscopy(SEM), X-ray diffractometry(XRD), differential scanning calorimetry(DSC), X-ray photoelectron spectroscopy(XPS), infrared spectroscopy(IR), ultraviolet spectroscopy(UV) and cytotoxicity test, and the drug loading and cumulative release rates were calculated. The results showed that Ti-MOF-79 was a regular long cylindrical crystal with porous structure. The results of in vitro experiments showed that the complexes with drug loading of (28.83±8.35)% had a sustained-release profile and had no obvious cytotoxicity, which indicated that MOF could become a novel carrier material.
Redox-responsive amphiphilic polymer, polyethylene glycol-cystamine-indometacin(PCI), was synthesized by conjugation of polyethylene glycol and the nonsteroidal anti-inflammatory agent indomethacin with disulfide bonds. The self-assembled micelles were prepared from the polymers by ultrasonic method to load the model antineoplastic agent, doxorubicin. Then, the title co-loaded polymeric micelles were obtained. The observation of transmission electron microscopy(TEM) revealed that the micelles were spherical in shape, and the results of dynamic light scattering showed that the average particle size and polydispersity index were (202.0±7.7)nm and 0.260±0.012, respectively. The encapsulation efficiency and drug loading of doxorubicin in the micelles were (90.71±3.78)% and(18.82±0.52)%, respectively. The cumulative release of doxorubicin from the micelles reached 80% in phosphate buffer(PBS) with glutathione(GSH) within 24 h, while in PBS without GSH was only about 40%. It was attributed to the redox-sensitive characteristics of disulfide bonds. The results of cytotoxicity experiments showed that the naked carriers had a certain antitumor effect on human hepatoma cells(HepG2 cells), while the co-loaded micelles presented enhanced antitumor effect on HepG2 cells. However, compared with free doxorubicin, the cytotoxicity of co-loaded micelles was weaker after 24 h co-incubation with HepG2 cells. The results of uptake experiments revealed that the cellular uptake of micelles in HepG2 cells was time-dependent.